Trial intelligence / Profile preview

Povidone-iodine versus chlorhexidine for prevention of early infection with central venous access device insertion in children

2006-000675-15Phase 4Completed

Sponsor
Great Ormond Street Hospital
Start
Sep 2006
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial in sepsis, catheter-associated bloodstream infection (CRBSI) and central line-associated bloodstream infection (CLABSI) comparing 10% povidone-iodine with alcohol with 0.5% chlorhexidine with 70% alcohol (2 arms). Primary endpoint: Sepsis by day 30. Started Sep 2006; status: completed.

02

Drugs

povidone-iodinechlorhexidine
03

Conditions

sepsiscatheter-associated bloodstream infection (CRBSI)central line-associated bloodstream infection (CLABSI)

Beyond the preview

Go deeper on 2006-000675-15.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-000675-15.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call